Results
Norris Medicines FY26 Net Loss ₹28.06 Lakhs
Norris Medicines reported audited FY26 results with a net loss of ₹28.06 lakhs, though Q4 showed a profit of ₹5.06 lakhs.
The board appointed M/s. Dhiren Y Parikh & Co. as Internal Auditors for FY 202
